Pharmaceutical Advertising and Promotion in China: Practical Compliance Guide
Drug promotion in China is not a creative problem first—it is a controlled claims and channel problem. Marketing, medical affairs, and compliance must share one intended-use spine or the organisation invents three different products.
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, and clinical trial regimes. This is not legal advice and does not create an attorney–client relationship. Instruct qualified PRC counsel before you act.
Beyond TV and print: WeChat, KOL livestreams, patient education that names products, conference booths, MSR/MR detailing aids, and “medical science” decks that effectively sell. If it influences prescribing or purchase, run medical-legal review—do not hide behind “internal training” labels when materials leave the company.
Claim and audience controls
Align all claims to the approved China label / instructions—no global brochure copy-paste.
Disease-awareness campaigns need bright lines so they do not become product ads for prescription drugs.
Comparative claims and “first / only / best” language need evidence and often heightened risk.
Patient-facing vs HCP-facing versions must not contradict each other.
Off-label promotion risk
HCPs may use products off-label; manufacturers create exposure when promotion, MSL scripts, or patient materials push unapproved indications or doses. Train for reactive scientific exchange protocols; document unsolicited requests. Liability and labeling interface: labeling & ADR guide.
Medical representatives & HCP engagement
MR activity sits at the junction of advertising rules and anti-bribery controls. Speaker fees, advisory boards, and hospitality need FMV and substance files — dawn raid playbook. Detailing aids should be version-controlled like regulated labels.
Internet, e-commerce & internet hospitals
Online channels amplify false-advertising and prescription-drug promotion risks. Platform pharmacies and internet hospitals have their own licensing overlay — internet hospital guide. Influencer contracts must include take-down and script-approval rights.
Medical-legal review operating model
Single intake queue for all external-facing content.
Reviewers: medical + legal + compliance (and regulatory when claims change).
Retention of approved versions and rejection logs for inspections.
Agency clauses: no publication without approval; audit rights; indemnity for rogue posts.
Enforcement & remedies posture
Expect advertising orders, fines, corrective statements, and traffic-platform takedowns. Parallel civil unfair-competition claims from competitors appear when comparative ads overreach. Coordinate response with PV if safety claims are implicated.
90-day uplift plan
Inventory all live WeChat/web assets against current China label.
Kill orphan PDFs on sales laptops.
Rebuild speaker-fee SOP with FMV grid.
Tabletop a false-ad complaint with comms + legal.
FAQ · 高频检索问题
医药代表超说明书推广厂家是否连带？
Promotion that pushes off-label use raises manufacturer exposure—control scripts, training, and incentives; investigate rogue behaviour with documentation.
处方药能否在互联网做广告？
Prescription-drug advertising is tightly restricted. Most consumer-facing product push is non-compliant; use counsel-approved pathways only.
学术会议赞助如何合规？
Scientific agenda, FMV, selection independent of purchase volume, and complete files—see anti-corruption guide.
Source register · primary authorities and verification
Sources & trust
How to use this guide
Primary sources cited on this page: Align all claims to the approved China label / instructions�no global brochure copy-paste.; Disease-awareness campaigns need bright lines so they do not become product ads for prescription drugs.; Comparative claims and �first / only / best� language need evidence and often heightened risk.; Patient-facing vs HCP-facing versions must not contradict each other.; Single intake queue for all external-facing content.; Reviewers: medical + legal + compliance (and regulatory when claims change).; Retention of approved versions and rejection logs for inspections.; Agency clauses: no publication without approval; audit rights; indemnity for rogue posts.; Inventory all live WeChat/web assets against current China label..
Editorial, AI and verification policies
This page is general information for orientation. It is not legal advice and does not create an attorney–client relationship.
Legal boundary: Prefer primary statutes, judicial interpretations, and official guidance when making decisions. Where this guide links to city hubs or lawyer listings, verify credentials and engagement terms directly with counsel. Full disclaimer · Submit an initial enquiry.
Consultation preparation
What to prepare before contacting counsel
Send a focused first package so counsel can check conflicts, understand scope, and identify urgent deadlines.
A concise timeline and the result you want to achieve.
Names of all parties and affiliates for a conflict check.
Key contracts, notices, correspondence, filings, or decisions.
Known deadlines, preferred language, location, and budget constraints.
Topic counsel
Counsel shortlist for this guide
Profiles matched by practice to this topic. A shortlist for consultation — not an endorsement of any filing, clearance or legal outcome.
Practice-matchedVerified status shown per profileFree initial consultation
